Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromes. [electronic resource]
- Leukemia research Dec 2007
- S16-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0145-2126
10.1016/S0145-2126(07)70462-9 doi
Benzoates--therapeutic use Deferasirox Deferiprone Drug-Related Side Effects and Adverse Reactions Humans Iron Chelating Agents--adverse effects Iron Overload--drug therapy Myelodysplastic Syndromes--therapy Pyridones--adverse effects Survival Rate Transfusion Reaction Treatment Outcome Triazoles--therapeutic use